HLTH USA 2026
Powerful Medical will be at HLTH to meet partners, investors and health system leaders. If you're attending and want to talk about bringing AI-powered cardiac diagnostics to your organisation, book a meeting with our team.
Las Vegas, Nevada, USA
November 15–18, 2026
HLTH USA bills itself as healthcare's #1 innovation event, and the scale backs it up: 12,250+ attendees, more than 4,400 C-suite executives, 950+ exhibitors, 150+ media outlets and thousands of pre-arranged meetings over four days at the Venetian on the Las Vegas Strip.
Under the 2026 theme "The Age of Intelligent Healthcare is Here," the programme covers AI and emerging technology, care delivery, health policy, investment strategy, pharma and life sciences, diagnostics and more, with main-stage keynotes, parallel insight programmes, a dedicated AI Zone, a Startup Pitch Tournament and nightly networking receptions. It is where health systems, payers, investors and technology companies meet under one roof.
- Venue: The Venetian Expo Center, Las Vegas, Nevada, USA
- Organiser: HLTH Inc.
- Website: hlth.com
Share this article
About PMcardio
PMcardio features FDA-authorized and CE-marked AI ECG models that interpret any 12-lead ECG — from a photo or a digital file — in seconds. It detects 50+ ECG findings, including occlusion myocardial infarction (OMI) — the acute coronary occlusions that conventional STEMI criteria miss in over half of cases. Its Queen of Hearts™ OMI model holds FDA Breakthrough Device Designation, and PMcardio is already used by 100,000+ clinicians who have analyzed more than 2.5 million ECGs.
About Powerful Medical
Powerful Medical is a medical-technology company using artificial intelligence to transform how cardiovascular disease — the world’s leading cause of death — is diagnosed. Founded in 2017, it built PMcardio, the world’s first AI medical device to detect acute coronary occlusion (OMI) from an ECG. Its research is published in the European Heart Journal – Digital Health and validated across 25+ clinical studies, and its Queen of Hearts™ model earned FDA Breakthrough Device Designation. To date, PMcardio has supported the detection of 120,000+ heart attacks across 150+ hospital deployments worldwide.